CREON
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis
Conditions
Cystic Fibrosis, Chronic Pancreatitis
Trial Timeline
Oct 14, 2021 → Aug 28, 2023
NCT ID
NCT05069597About CREON
CREON is a approved stage product being developed by AbbVie for Cystic Fibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT05069597. Target conditions include Cystic Fibrosis, Chronic Pancreatitis.
What happened to similar drugs?
20 of 20 similar drugs in Cystic Fibrosis were approved
Approved (20) Terminated (7) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05069597 | Approved | Completed |
| NCT04949828 | Pre-clinical | Completed |
| NCT04315311 | Approved | Withdrawn |
Competing Products
20 competing products in Cystic Fibrosis